News for AstraZeneca plc - Google Finance

3 Neil Woodford High-Yield Shares: AstraZeneca plc, BAE Systems plc And SSE ...

Mon, 20 May 2013 14:57:16 GMT

3 Neil Woodford High-Yield Shares: AstraZeneca plc, BAE Systems plc And SSE ...
Motley Fool UK - May 20, 2013

AstraZeneca plc (LON:AZN), BAE Systems plc (LON:BA) and SSE PLC (LON:SSE) are three of the master investor's high-income shares.

ASTRAZENECA PLC : Results from Phase III Studies of Naloxegol for Treatment ...

Tue, 21 May 2013 13:28:06 GMT

ASTRAZENECA PLC : Results from Phase III Studies of Naloxegol for Treatment ...
4-traders (press release) - 22 hours ago

AstraZeneca (NYSE: AZN) today presented the results of two pivotal Phase III studies of naloxegol showing the 25 mg dose of the investigational drug met its primary and secondary endpoints for efficacy and showed a safety profile consistent with ...

AstraZeneca's Naloxegol Meets Primary End Point In Late-stage Trial - NASDAQ

ASTRAZENECA PLC : AstraZeneca closes in on site for new home in Cambridge

Mon, 20 May 2013 14:36:38 GMT

ASTRAZENECA PLC : AstraZeneca closes in on site for new home in Cambridge
4-traders (press release) - May 20, 2013

With outline planning consent for 70 acres to accommodate up to 2.3 million square feet of new buildings, there is plenty of room for the purpose-built global research centre and corporate headquarters that AstraZeneca plans to establish by 2016 at ...

Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) - Pick ...

Mon, 20 May 2013 14:57:20 GMT

Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) - Pick ...
Insider Monkey (blog) - May 20, 2013

The study, published in the Journal of the American College of Cardiology, used Merck & Co., Inc. (NYSE:MRK)'s Zocor, but it seems safe to assume that other statins -- Pfizer Inc. (NYSE:PFE)'s Lipitor and AstraZeneca plc (ADR) (NYSE:AZN)'s Crestor ...

A Closer Look At AstraZeneca Plc's Dividend Potential

Tue, 14 May 2013 10:46:04 GMT

A Closer Look At AstraZeneca Plc's Dividend Potential
Motley Fool UK - May 14, 2013

Is AstraZeneca plc (LON: AZN) a solid pick for dividend growth? Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.

A Closer Look at GlaxoSmithKline's Dividend Potential - Motley Fool

Is AstraZeneca Plc The Ultimate Stock-Pickers Share?

Mon, 29 Apr 2013 09:56:18 GMT

Is AstraZeneca Plc The Ultimate Stock-Pickers Share?
Motley Fool UK - Apr 29, 2013

The shares of AstraZeneca plc (LON:AZN) pass a large number of popular investment screens. Does this mean that they are set to rocket?

Is AstraZeneca the Ultimate Stock Picker's Share? - Motley Fool

Why Unilever plc, AstraZeneca plc And Kier Group plc Should Lag The FTSE ...

Thu, 25 Apr 2013 12:02:29 GMT

Why Unilever plc, AstraZeneca plc And Kier Group plc Should Lag The FTSE ...
Motley Fool UK - Apr 25, 2013

Unilever plc (LON: ULVR), AstraZeneca plc (LON: AZN) and Kier Group plc (LON: KIE) are all falling. The FTSE 100 dipped early this morning, despite the news that the UK economy has so far avoided a triple-dip recession by growing 0.3% in the first ...

AstraZeneca plc + Taylor Wimpey plc : AZN and TW stock see differing fortunes ... - Economy News

ASTRAZENECA PLC : Assessing Your Asthma is Key to Taking Control

Mon, 13 May 2013 19:09:28 GMT

ASTRAZENECA PLC : Assessing Your Asthma is Key to Taking Control
4-traders (press release) - May 13, 2013

WILMINGTON, Del., May 13, 2013 /PRNewswire/ -- Approximately 25 million Americans suffer from asthma, which accounts for more than 3300 deaths each year.

ASTRAZENECA PLC : Sub-Group Analysis Shows Investigational Metreleptin ...

Mon, 06 May 2013 11:10:49 GMT

ASTRAZENECA PLC : Sub-Group Analysis Shows Investigational Metreleptin ...
4-traders (press release) - May 6, 2013

Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced the results from a 12-month sub-group analysis of a National Institutes of Health (NIH), open-label, long-term research study of metreleptin, an investigational ...

Bristol-Myers, AstraZeneca: Study Shows Metreleptin May Treat Pediatric ... - Wall Street Journal

Director Deals - AstraZeneca PLC (AZN)

Mon, 29 Apr 2013 14:18:19 GMT

Director Deals - AstraZeneca PLC (AZN)
Stock Market Wire - Apr 29, 2013

Director Deals - AstraZeneca PLC (AZN). 29 April 2013 | 15:15pm. StockMarketWire.com - Simon Lowth, Financial Director, sold post-exercise 54,561 shares in the company on the 26th April 2013 at a price of 3316.00p.